20/20 Biolabs annual revenue
2023
2024
2025
20/20 Biolabs Revenue Growth & History (AIDX)
20/20 Biolabs reported $2.0M in revenue for fiscal 2025, an increase of 16.71% from the previous fiscal year.
View full 20/20 Biolabs company overview20/20 Biolabs annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.0M | $292,790 | +16.71% |
| 2024 | 2024-12-31 | $1.8M | $328,039 | +23.03% |
| 2023 | 2023-12-31 | $1.4M | — | — |
20/20 Biolabs quarterly revenue
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $730,571 | $195,511 | +36.54% |
| Q1 2026 | 2026-03-31 | $353,375 | −$200,445 | −36.19% |
| Q4 2025 | 2025-12-31 | $538,274 | $2,190 | +0.41% |
| Q3 2025 | 2025-09-30 | $417,979 | — | — |
| Q2 2025 | 2025-06-30 | $535,060 | — | — |
| Q1 2025 | 2025-03-31 | $553,820 | — | — |
| Q4 2024 | 2024-12-31 | $536,084 | — | — |
20/20 Biolabs revenue growth trends
20/20 Biolabs's latest reported quarter, Q2 2026, generated $730,571 in revenue, an increase of 36.54% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review 20/20 Biolabs source filings ↗